Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
STAR Protocols
|
October 28, 2020
High-Throughput Mass Cytometry Staining for Immunophenotyping Clinical Samples
Emily M Thrash, Katja Kleinsteuber, Emma S Hathaway, et al.
Blood
|
March 8, 2021
Activation of the MAPK pathway mediates resistance to PI3K inhibitors in chronic lymphocytic leukemia
Ishwarya Murali, Siddha Kasar, Aishath Naeem, et al.
Blood Advances
|
August 25, 2021
Coevolving JAK2V617F+relapsed AML and donor T cells with PD-1 blockade after stem cell transplantation: an index case
Livius Penter, Satyen H Gohil, Teddy Huang, et al.
Leukemia
|
July 28, 2025
Rare germline variant in NFATC4 associated with familial CLL
Gilad Itchaki, Harrison Bai, Grace Tiao, et al.
Cancer Immunology Research
|
April 11, 2025
First-in-Human Clinical Trial of Vaccination with WDVAX, a Dendritic Cell Activating Scaffold Incorporating Autologous Tumor Cell Lysate, in Metastatic Melanoma Patients
F Stephen Hodi, Anita Giobbie-Hurder, Kwasi Adu-Berchie, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
August 1, 2019
A Modified Injector and Sample Acquisition Protocol Can Improve Data Quality and Reduce Inter-Instrument Variability of the Helios Mass Cytometer
Brian H Lee, Geoffrey Kelly, Shermineh Bradford, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 12, 2020
A Randomized Phase 2 Study of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
Umair Mahmood, Andrew Bang, Yu-Hui Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 16, 2021
Immune Profiling Mass Cytometry Assay Harmonization: Multicenter Experience from CIMAC-CIDC
Bita Sahaf, Mina Pichavant, Brian H Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 2, 2021
Correction: A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer
Arta M Monjazeb, Anita Giobbie-Hurder, Ana Lako, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2021
A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer
Arta M Monjazeb, Anita Giobbie-Hurder, Ana Lako, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
STAR Protocols
|
October 28, 2020
High-Throughput Mass Cytometry Staining for Immunophenotyping Clinical Samples
Emily M Thrash, Katja Kleinsteuber, Emma S Hathaway, et al.
Blood
|
March 8, 2021
Activation of the MAPK pathway mediates resistance to PI3K inhibitors in chronic lymphocytic leukemia
Ishwarya Murali, Siddha Kasar, Aishath Naeem, et al.
Blood Advances
|
August 25, 2021
Coevolving JAK2V617F+relapsed AML and donor T cells with PD-1 blockade after stem cell transplantation: an index case
Livius Penter, Satyen H Gohil, Teddy Huang, et al.
Leukemia
|
July 28, 2025
Rare germline variant in NFATC4 associated with familial CLL
Gilad Itchaki, Harrison Bai, Grace Tiao, et al.
Cancer Immunology Research
|
April 11, 2025
First-in-Human Clinical Trial of Vaccination with WDVAX, a Dendritic Cell Activating Scaffold Incorporating Autologous Tumor Cell Lysate, in Metastatic Melanoma Patients
F Stephen Hodi, Anita Giobbie-Hurder, Kwasi Adu-Berchie, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
August 1, 2019
A Modified Injector and Sample Acquisition Protocol Can Improve Data Quality and Reduce Inter-Instrument Variability of the Helios Mass Cytometer
Brian H Lee, Geoffrey Kelly, Shermineh Bradford, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 12, 2020
A Randomized Phase 2 Study of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
Umair Mahmood, Andrew Bang, Yu-Hui Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 16, 2021
Immune Profiling Mass Cytometry Assay Harmonization: Multicenter Experience from CIMAC-CIDC
Bita Sahaf, Mina Pichavant, Brian H Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 2, 2021
Correction: A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer
Arta M Monjazeb, Anita Giobbie-Hurder, Ana Lako, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2021
A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer
Arta M Monjazeb, Anita Giobbie-Hurder, Ana Lako, et al.
Page
of 2